Seller comparison · US self-pay prices

Ivim Health vs Ro: GLP-1 Prices Compared

Ivim Health and Ro both sell Zepbound injection. Zepbound injection: not ranked against each other, because only Ro's is a first-month price: Ivim Health advertises $373.99/mo ($299 medication + $74.99 monthly membership/provider fee), Ro $338 first month ($299 medication + $39 first-month membership/provider fee). Only Ivim Health sells compounded semaglutide injection, compounded tirzepatide injection, Wegovy pill, and Foundayo pill here. Only Ro sells Wegovy injection here. What each sells here: Ivim Health, FDA-approved brand-name GLP-1s and compounded versions; Ro, FDA-approved brand-name GLP-1s only. Compounded GLP-1s are not FDA-approved. Prices checked Oct 13, 2026 and Oct 17, 2026.

Every cash quote was checked on or after . Each quote shows its own check date. A quoted price is not a recommendation of a seller, a product or a dose. How we source prices

Same product

What Ivim Health and Ro charge for the same medication

Entry prices first, then the published top-dose price where either seller states one. Each price links the seller's own page.

Zepbound injection

Entry price: not ranked against each other, because only Ro's is a first-month price: Ivim Health advertises $373.99/mo ($299 medication + $74.99 monthly membership/provider fee), Ro $338 first month ($299 medication + $39 first-month membership/provider fee). Top dose: the monthly total is $74.01 lower at Ivim Health: Ivim Health $523.99/mo ($449 medication + $74.99 monthly membership/provider fee) at 15 mg, Ro $598/mo ($449 medication + $149 monthly membership/provider fee) at 15 mg.

IHIvim Health

Advertised entry price

$373.99/mo

Calculated: $299 medication + $74.99 ongoing membership/provider fee. Charges billed separately.

Separate billing cycles; excluded from cost ranking.

Checked

Zepbound KwikPen via Ivim Health

Ivim Health · Sourced provider quote

Price conditions

Calculated: $299 medication + $74.99 ongoing membership/provider fee

A 1-month supply at 2.5 mg; the medication prices match Eli Lilly's own self-pay prices. FDA-approved product.

Published maintenance dose

$523.99/mo

Calculated: $449 medication + $74.99 ongoing membership/provider fee. Charges billed separately.

Separate billing cycles; excluded from cost ranking.

Checked

At 15 mg

Zepbound KwikPen via Ivim Health

Ivim Health · Sourced provider quote

Price conditions

Calculated: $449 medication + $74.99 ongoing membership/provider fee

A 1-month supply at 2.5 mg; the medication prices match Eli Lilly's own self-pay prices. FDA-approved product.

Ivim lists $449 of medication at 7.5 to 15 mg, for vials and KwikPens alike.

RRo

Advertised entry price

$338 first month

Calculated: $299 medication + $39 introductory membership/provider fee. Charges billed separately.

Membership then $149/month, plus medication.

Separate billing cycles; excluded from cost ranking.

Checked

Zepbound KwikPen via Ro Body

Ro · Sourced provider quote

Price conditions

Calculated: $299 medication + $39 introductory membership/provider fee

Starting medication dose: 2.5 mg. Membership renews at $149/month on the monthly plan. Medication costs rise with dose. Medication and membership are two separate charges.

Membership then $149/month, plus medication.

Published maintenance dose

$598/mo

Calculated: $449 medication + $149 ongoing membership/provider fee. Charges billed separately.

Separate billing cycles; excluded from cost ranking.

Checked

At 15 mg

Zepbound KwikPen via Ro Body

Ro · Sourced provider quote

Price conditions

Calculated: $449 medication + $149 ongoing membership/provider fee

Starting medication dose: 2.5 mg. Membership renews at $149/month on the monthly plan. Medication costs rise with dose. Medication and membership are two separate charges.

Monthly membership plus the manufacturer's offer price Ro lists for 7.5 mg and higher doses.

Sold by one of them

What only one of them sells

Both sell semaglutide, as different products: compounded semaglutide injection and Wegovy pill at Ivim Health, Wegovy injection at Ro.

IHIvim Health
  • Compounded semaglutide injection

    Advertised entry price

    $224.99/mo

    Calculated: $150 medication + $74.99 ongoing membership/provider fee. Charges billed separately.

    Separate billing cycles; excluded from cost ranking.

    Checked

    Compounded semaglutide via Ivim Health

    Ivim Health · Sourced provider quote

    Price conditions

    Calculated: $150 medication + $74.99 ongoing membership/provider fee

    1-month program. On 12 months the medication is $780 ($65 a month) plus $899.88 of membership, $1,679.88 in all; compounded programs are paid upfront and the membership runs for the whole plan. Other Ivim pages show $75, $140 or $149 a month for semaglutide. Compounded; not FDA-approved.

  • Compounded tirzepatide injection

    Advertised entry price

    $324.99/mo

    Calculated: $250 medication + $74.99 ongoing membership/provider fee. Charges billed separately.

    Separate billing cycles; excluded from cost ranking.

    Checked

    Compounded tirzepatide via Ivim Health

    Ivim Health · Sourced provider quote

    Price conditions

    Calculated: $250 medication + $74.99 ongoing membership/provider fee

    1-month program. On 12 months the medication is $1,400 (about $117 a month) plus $899.88 of membership, $2,299.88 in all, paid upfront. Other Ivim pages show $133 or $192 a month for tirzepatide. Compounded; not FDA-approved.

  • Wegovy pill

    Advertised entry price

    $223.99/mo

    Calculated: $149 medication + $74.99 ongoing membership/provider fee. Charges billed separately.

    Separate billing cycles; excluded from cost ranking.

    Checked

    Wegovy pill via Ivim Health

    Ivim Health · Sourced provider quote

    Price conditions

    Calculated: $149 medication + $74.99 ongoing membership/provider fee

    A 1-month supply at 1.5 mg; $199 of medication at 4 mg on this product line, though another Ivim page lists 4 mg at $149. FDA-approved product.

    Published maintenance dose

    $373.99/mo

    Calculated: $299 medication + $74.99 ongoing membership/provider fee. Charges billed separately.

    Separate billing cycles; excluded from cost ranking.

    Checked

    At 25 mg

    Wegovy pill via Ivim Health

    Ivim Health · Sourced provider quote

    Price conditions

    Calculated: $299 medication + $74.99 ongoing membership/provider fee

    A 1-month supply at 1.5 mg; $199 of medication at 4 mg on this product line, though another Ivim page lists 4 mg at $149. FDA-approved product.

  • Foundayo pill

    Advertised entry price

    $223.99/mo

    Calculated: $149 medication + $74.99 ongoing membership/provider fee. Charges billed separately.

    Separate billing cycles; excluded from cost ranking.

    Checked

    Foundayo via Ivim Health

    Ivim Health · Sourced provider quote

    Price conditions

    Calculated: $149 medication + $74.99 ongoing membership/provider fee

    A 1-month supply at 0.8 mg ($149 of medication at 2.5 mg too). FDA-approved product.

    Published maintenance dose

    $373.99/mo

    Calculated: $299 medication + $74.99 ongoing membership/provider fee. Charges billed separately.

    Separate billing cycles; excluded from cost ranking.

    Checked

    At 17.2 mg

    Foundayo via Ivim Health

    Ivim Health · Sourced provider quote

    Price conditions

    Calculated: $299 medication + $74.99 ongoing membership/provider fee

    A 1-month supply at 0.8 mg ($149 of medication at 2.5 mg too). FDA-approved product.

    $299 of medication from 9 mg up; $199 at 5.5 mg.

RRo
  • Wegovy injection

    Advertised entry price

    $238 first month

    Calculated: $199 medication + $39 introductory membership/provider fee. Charges billed separately.

    Membership then $149/month, plus medication.

    Separate billing cycles; excluded from cost ranking.

    Offer through

    Checked

    Wegovy pen via Ro Body

    Ro · Sourced provider quote

    Price conditions

    Calculated: $199 medication + $39 introductory membership/provider fee

    $199 medication for the first two months at 0.25 or 0.5 mg, for patients who sign up by Dec 31, 2026; then $349 at 1 to 2.4 mg. Membership renews at $149/month on the monthly plan, or $99, $89 or $74 a month prepaid for 3, 6 or 12 months. Medication and membership are two separate charges.

    Membership then $149/month, plus medication.

    Published maintenance dose

    $498/mo

    Calculated: $349 medication + $149 ongoing membership/provider fee. Charges billed separately.

    Separate billing cycles; excluded from cost ranking.

    Checked

    At 2.4 mg

    Wegovy pen via Ro Body

    Ro · Sourced provider quote

    Price conditions

    Calculated: $349 medication + $149 ongoing membership/provider fee

    $199 medication for the first two months at 0.25 or 0.5 mg, for patients who sign up by Dec 31, 2026; then $349 at 1 to 2.4 mg. Membership renews at $149/month on the monthly plan, or $99, $89 or $74 a month prepaid for 3, 6 or 12 months. Medication and membership are two separate charges.

    Monthly membership plan; prepaid plans have different rates.

Compounded GLP-1s are not FDA-approved. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. FDA: concerns with unapproved GLP-1 drugs used for weight loss

Every sourced offer

All Ivim Health and Ro offers

Both sellers' quotes in one table, lowest 30-day cost first where the seller states its supply.

7 offers · US self-pay

Read prices in context. Compare the same product, dose, and payment terms. A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes with documented supply periods, converted to 30 days. Other prices are unranked references. Dose changes, introductory terms and added fees affect what you pay.

Missing prices are not estimated. A listed maintenance dose is not a dosing recommendation.

The FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved, ending the exemption that let pharmacies mass-produce compounded copies, and the 503A/503B enforcement-discretion grace periods ended in 2025. The FDA is now actively enforcing (warning letters and takedowns, including a September 2026 warning letter to Empower Pharmacy, a large compounder, over products it called essentially copies of approved semaglutide and tirzepatide), and in 2026 proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list (the public comment period, extended 30 days, closed July 30, 2026; a final decision is pending). Liraglutide is different: it is still on the FDA drug shortage list (brand Victoza and Saxenda in limited supply, generics available, as of September 2026). Compounded GLP-1s are not FDA-approved and are now generally limited to narrow, patient-specific 503A prescriptions, so broad low-cost availability has largely wound down. They also carry safety risks the branded products do not: FDA adverse-event reports, at least one sterility recall (ProRx, October 2025), and counterfeit product found in the US supply chain, so a low price is not a low-risk signal. Prices and availability below may lag these changes; confirm current terms with the provider.

Questions

Ivim Health vs Ro: common questions

Is Ivim Health or Ro cheaper for GLP-1 medication?

Zepbound injection: not ranked against each other, because only Ro's is a first-month price: Ivim Health advertises $373.99/mo ($299 medication + $74.99 monthly membership/provider fee), Ro $338 first month ($299 medication + $39 first-month membership/provider fee). At the top published dose, the monthly total is $74.01 lower at Ivim Health: Ivim Health $523.99/mo ($449 medication + $74.99 monthly membership/provider fee) at 15 mg, Ro $598/mo ($449 medication + $149 monthly membership/provider fee) at 15 mg. Only Ivim Health: Compounded semaglutide injection $224.99/mo ($150 medication + $74.99 monthly membership/provider fee); Compounded tirzepatide injection $324.99/mo ($250 medication + $74.99 monthly membership/provider fee); Wegovy pill $223.99/mo ($149 medication + $74.99 monthly membership/provider fee); Foundayo pill $223.99/mo ($149 medication + $74.99 monthly membership/provider fee). Only Ro: Wegovy injection $238 first month ($199 medication + $39 first-month membership/provider fee). Prices are the sellers' own advertised self-pay prices, with the conditions listed beside each.

Do Ivim Health and Ro sell FDA-approved GLP-1s or compounded versions?

What each sells here: Ivim Health, FDA-approved brand-name GLP-1s and compounded versions; Ro, FDA-approved brand-name GLP-1s only. Compounded GLP-1s are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality.

What do Ivim Health and Ro prices include?

Ivim Health, Zepbound injection: $373.99/mo ($299 medication + $74.99 monthly membership/provider fee). Ro, Zepbound injection: $338 first month ($299 medication + $39 first-month membership/provider fee); membership then $149/month, plus medication. Ivim Health, compounded semaglutide injection: $224.99/mo ($150 medication + $74.99 monthly membership/provider fee). Ivim Health, compounded tirzepatide injection: $324.99/mo ($250 medication + $74.99 monthly membership/provider fee). Ivim Health, Wegovy pill: $223.99/mo ($149 medication + $74.99 monthly membership/provider fee). Ivim Health, Foundayo pill: $223.99/mo ($149 medication + $74.99 monthly membership/provider fee). Ro, Wegovy injection: $238 first month ($199 medication + $39 first-month membership/provider fee); membership then $149/month, plus medication.

When were Ivim Health and Ro prices last checked?

Prices checked Oct 13, 2026 and Oct 17, 2026. Each quote links the seller's own page it was read from. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.